THYROCARE drops 10.6% to reach ₹460.90
Key Highlights
Thyrocare Technologies Ltd. shares fell 10.59% to ₹460.90 as of 11:29 IST on 30 October 2026. The company reported a net profit of ₹15 crore.
- THYROCARE fell 10.59% to ₹460.90 at 11:29 IST on 30 Oct 2026.
- so far was 7.61× its 20-session average.
- Q2 FY27 net profit: ₹15 crore, −68.17% on a year earlier.
Figures as of: 11:29 IST, Friday 30 October 2026
Thyrocare Technologies Ltd. (THYROCARE) fell 10.59% to ₹460.90 at 11:29 IST on Friday 30 October 2026. Trading volume reached 7.61× the 20-session average of 3.5 lakh shares. The company filed its Q2 FY27 results on Thursday 29 October 2026, and the share price traded at ₹460.90 on Friday. The Q2 FY27 net profit was ₹15 crore.
THYROCARE share price today
| Price (11:29 IST) | ₹460.90 |
| Change from the previous close (₹515.50) | −₹54.60 (−10.59%) |
| Day’s range | ₹460.25 – ₹503.50 |
| Volume so far | 26.3 lakh shares |
| 20-session average daily volume | 3.5 lakh shares (volume so far is 7.61× that) |
| Closing prices of the previous 4 sessions | ₹463.15 – ₹494.50 |
| 52-week range (adjusted prices) | ₹342.55 – ₹662.00 |
| Price against that range | 30.4% below the high, 34.5% above the low |
| Market value at this price | ₹7,336 crore |
The share price traded between ₹460.25 and ₹503.50 during the session. Volume reached 26.3 lakh shares, which is 7.61× the 20-session average daily volume of 3.5 lakh shares. The current price of ₹460.90 is 30.4% below the 52-week high of ₹662.00.
What has been announced
| When (IST) | Filing |
|---|---|
| Thu 29 Oct, 4:17 pm | Announcement under Regulation 30 (LODR)-Investor Presentation |
| Thu 29 Oct, 4:10 pm | Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Thu 29 Oct, 3:59 pm | Unaudited Financial Results For The Quarter And Half Year Ended September 30 2026 |
| Thu 29 Oct, 3:54 pm | Board Meeting Outcome for Outcome Of The Board Meeting Held On October 29 2026 |
Q2 FY27 results at a glance
| ₹ crore | Q2 FY27 | Q2 FY26 | Change | Q1 FY27 | Change |
|---|---|---|---|---|---|
| from operations | 271 | 217 | +25.07% | 240 | +12.83% |
| 34 | 63 | −46.23% | 68 | −50.72% | |
| Net profit | 15 | 48 | −68.17% | 51 | −70.35% |
| Net profit as a share of revenue | 5.62% | 22.08% | – | 21.39% | – |
For the quarter ended 30 September 2026, the company reported revenue from operations of ₹271 crore. Profit before tax reached ₹34 crore, which is a 46.23% change on a year earlier. Net profit for Q2 FY27 was ₹15 crore, representing a 68.17% change on a year earlier.
How THYROCARE compares with its sector
| Change today | |
|---|---|
| THYROCARE | −10.59% |
| +0.48% |
The Hospital & Healthcare Services stock declined 10.59% while the Nifty 50 index added 0.48% during the same period. Thyrocare Technologies Ltd. (THYROCARE) currently holds a market value of ₹7,336 crore. The Nifty 50 index added 0.48% as the stock price fell 10.59%.
THYROCARE share price: FAQs
What is the THYROCARE share price today?
₹460.90 at 11:29 IST on Friday 30 October 2026, down ₹54.60 or 10.59% from the previous close of ₹515.50.
What were THYROCARE’s Q2 FY27 results?
revenue from operations of ₹271 crore (+25.07% year on year) and net profit of ₹15 crore (−68.17%), for the quarter ended 30 September 2026.
When did THYROCARE announce the results?
The board meeting outcome was filed on Thu 29 Oct, 3:59 pm IST.
This article is for information only and is not investment advice. Prices are from the National Stock Exchange, filings from BSE announcements and results from the company’s reported figures. Calculations are by ThePip. Prices and figures move through the session; the time above says when these were read. Investments in securities are subject to market risks.